Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 5/2005

01-05-2005 | Original Paper

New tumor necrosis factor-α-inducing protein released from Helicobacter pylori for gastric cancer progression

Authors: Masami Suganuma, Miki Kurusu, Kaori Suzuki, Akira Nishizono, Kazunori Murakami, Toshio Fujioka, Hirota Fujiki

Published in: Journal of Cancer Research and Clinical Oncology | Issue 5/2005

Login to get access

Abstract

Purpose

To investigate the association between Helicobacter pylori infection and its inflammatory reaction in gastritis, gastric ulcer, and gastric cancer, a new tumor necrosis factor-α (TNF-α)-inducing protein of H. pylori was studied.

Methods

The HP0596 gene of H. pylori was identified as the TNF-α-inducing protein (Tipα) gene from genome sequence of H. pylori strain 26695. Using recombinant Tipα (rTipα) and deleted Tipα (rdel-Tipα) proteins, the latter of which lacks six amino acids containing two cysteines in the N-terminal domain, we examined their activities in TNF-α gene expression and NF-κB activation in both Bhas 42 (v-H-ras transfected BALB/3T3) cells and mouse gastric epithelial cell line MGT-40, and in vitro transformation of Bhas 42 cells.

Results

Tipα protein as a homodimer form (38 kDa) was found in both extracts and culture medium of various H. pylori strains. rTipα significantly induced TNF-α gene expression and NF-κB activation in both Bhas 42 cells and MGT-40, and induced in vitro transformation of Bhas 42 cells. However, rdel-Tipα did not. Treatment with MG-132, a proteasome inhibitor, inhibited translocation of NF-κB p65, and abrogated TNF-α induction induced by Tipα protein.

Conclusion

Tipα is a new carcinogenic factor released from H. pylori mediated through NF-κB activation.
Literature
go back to reference Alm RA, Ling L-S, Moir DT, King BL, Brown ED, Doig PC, Smith DR, Noonan B, Guild BC, deJonge BL, Carmel G, Tummino PJ, Caruso A, Uria-Nickelsen M, Mills DM, Ives C, Gibson R, Merberg D, Mills SD, Jiang Q, Taylor DE, Vovis GF, Trust TJ (1999) Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397:176–180CrossRef Alm RA, Ling L-S, Moir DT, King BL, Brown ED, Doig PC, Smith DR, Noonan B, Guild BC, deJonge BL, Carmel G, Tummino PJ, Caruso A, Uria-Nickelsen M, Mills DM, Ives C, Gibson R, Merberg D, Mills SD, Jiang Q, Taylor DE, Vovis GF, Trust TJ (1999) Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397:176–180CrossRef
go back to reference Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S (2003) Japan Helicobacter pylori Eradication Study Group. Follow-up survey of a large-sclae multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroenterol 38:339–347CrossRef Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S (2003) Japan Helicobacter pylori Eradication Study Group. Follow-up survey of a large-sclae multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroenterol 38:339–347CrossRef
go back to reference Atherton JC, Cao P, Peek RM Jr, Tummuru MKR, Blaser MJ, Cover TL (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 270:17771–17777CrossRefPubMed Atherton JC, Cao P, Peek RM Jr, Tummuru MKR, Blaser MJ, Cover TL (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 270:17771–17777CrossRefPubMed
go back to reference Correa P (2003) Helicobacter pylori infection and gastric cancer. Cancer Epidemiol Biomarkers Prev 12:238s–241s Correa P (2003) Helicobacter pylori infection and gastric cancer. Cancer Epidemiol Biomarkers Prev 12:238s–241s
go back to reference Fujiki H, Suganuma M, Okabe S, Kurusu M, Imai K, Nakachi K (2002) Involvement of TNF-α changes in human cancer development, prevention and palliative care. Mech Ageing Dev 123:1655–1663CrossRef Fujiki H, Suganuma M, Okabe S, Kurusu M, Imai K, Nakachi K (2002) Involvement of TNF-α changes in human cancer development, prevention and palliative care. Mech Ageing Dev 123:1655–1663CrossRef
go back to reference Fujiki H, Takeuchi H, Nishitani N, Yamanaka H, Suzuki K, Kurusu M, Suganuma M (2004) Carcinogenic potential of tabacco tar-resistant Staphylococcus aureus in buccal cavity. J Cancer Res Clin Oncol 130:301–305CrossRef Fujiki H, Takeuchi H, Nishitani N, Yamanaka H, Suzuki K, Kurusu M, Suganuma M (2004) Carcinogenic potential of tabacco tar-resistant Staphylococcus aureus in buccal cavity. J Cancer Res Clin Oncol 130:301–305CrossRef
go back to reference Gobert AP, Bambou J-C, Werts C, Balloy V, Chignard M, Moran AP, Ferrero RL (2004) Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J Biol Chem 279:245–250CrossRef Gobert AP, Bambou J-C, Werts C, Balloy V, Chignard M, Moran AP, Ferrero RL (2004) Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J Biol Chem 279:245–250CrossRef
go back to reference IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) In: IARC Monographs on the evaluation of carcinogenic risks to humans, vol 61. Schistosomes, liver flukes and Helicobacter pylori. IARC, Lyon , pp 177–240 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) In: IARC Monographs on the evaluation of carcinogenic risks to humans, vol 61. Schistosomes, liver flukes and Helicobacter pylori. IARC, Lyon , pp 177–240
go back to reference Ichinose M, Nakanishi H, Fujino S, Tatematsu M (1998) Establishment and characterization of two cell lines from N-methyl-N-nitrosourea-induced mouse glandular stomach carcinomas. Jpn J Cancer Res 89:516–524 Ichinose M, Nakanishi H, Fujino S, Tatematsu M (1998) Establishment and characterization of two cell lines from N-methyl-N-nitrosourea-induced mouse glandular stomach carcinomas. Jpn J Cancer Res 89:516–524
go back to reference Karin M, Cao Y, Grete FR, Li Z-W (2002) NF-κB in cancer: from innocent bystander to major culprit. Nature Rev Cancer 2:301–310CrossRef Karin M, Cao Y, Grete FR, Li Z-W (2002) NF-κB in cancer: from innocent bystander to major culprit. Nature Rev Cancer 2:301–310CrossRef
go back to reference Ley C, Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Johnstone I, Parsonnet J (2004) Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev 13:4-10 Ley C, Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Johnstone I, Parsonnet J (2004) Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev 13:4-10
go back to reference Montemurro P, Barbuti G, Dundon WG, Del Giudice G, Rappuoli R, Colucci M, De Rinaldis P, Montecucco C, Semeraro N, Papini E (2001) Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J Infect Dis 183:1055–1062CrossRef Montemurro P, Barbuti G, Dundon WG, Del Giudice G, Rappuoli R, Colucci M, De Rinaldis P, Montecucco C, Semeraro N, Papini E (2001) Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J Infect Dis 183:1055–1062CrossRef
go back to reference Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G, Balkwill F (1999) Mice deficient in tumor necrosis factor- α are resistant to skin carcinogenesis. Nature Med 5:828–831CrossRef Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G, Balkwill F (1999) Mice deficient in tumor necrosis factor- α are resistant to skin carcinogenesis. Nature Med 5:828–831CrossRef
go back to reference Normark S, Nilsson C, Normark BH, Hornef MW (2003) Persistent infection with Helicobacter pylori and the development of gastric cancer. Adv Cancer Res 90:63–89CrossRef Normark S, Nilsson C, Normark BH, Hornef MW (2003) Persistent infection with Helicobacter pylori and the development of gastric cancer. Adv Cancer Res 90:63–89CrossRef
go back to reference Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R (2000) Translocation of Helicobacter pylori cagA into gastric epithelial cells by type IV secretion. Scinece 287:1497–1500CrossRef Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R (2000) Translocation of Helicobacter pylori cagA into gastric epithelial cells by type IV secretion. Scinece 287:1497–1500CrossRef
go back to reference Ohmori K, Sasaki K, Asada S, Tanaka N, Umeda M (2004) An assay method for the prediction of tumor promoting potential of chemicals by use of Bhas 42 cells. Mutat Res 552:191–202 Ohmori K, Sasaki K, Asada S, Tanaka N, Umeda M (2004) An assay method for the prediction of tumor promoting potential of chemicals by use of Bhas 42 cells. Mutat Res 552:191–202
go back to reference Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773–785PubMed Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773–785PubMed
go back to reference Peek RM Jr, Blaser MJ (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Rev Cancer 2:28–37CrossRef Peek RM Jr, Blaser MJ (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Rev Cancer 2:28–37CrossRef
go back to reference Perez AL, Kato M, Nakagawa S, Kawarasaki M, Nagasako T, Mizushima T, Oda H, Kodaira J, Shimizu Y, Komatsu Y, Zheng R, Takeda H, Sugiyama T, Asaka M (2002) The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 7:306–309CrossRef Perez AL, Kato M, Nakagawa S, Kawarasaki M, Nagasako T, Mizushima T, Oda H, Kodaira J, Shimizu Y, Komatsu Y, Zheng R, Takeda H, Sugiyama T, Asaka M (2002) The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 7:306–309CrossRef
go back to reference Sasaki K, Mizusawa H, Ishidate M, Tanaka N (1990) Transformation of RAS transfected BALB 3T3 clone (Bhas 42) by promoters: application for screening and specificity of promoters. Toxicol In Vitro 4:657–659CrossRef Sasaki K, Mizusawa H, Ishidate M, Tanaka N (1990) Transformation of RAS transfected BALB 3T3 clone (Bhas 42) by promoters: application for screening and specificity of promoters. Toxicol In Vitro 4:657–659CrossRef
go back to reference Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M (1999) Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 20:669–676CrossRefPubMed Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M (1999) Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 20:669–676CrossRefPubMed
go back to reference Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A (1997) High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 32:465–468 Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A (1997) High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 32:465–468
go back to reference Sueoka E, Sueoka N, Okabe S, Komori A, Suganuma M, Kozu T, Fujiki H (1998) Tumorigenicity of MTG8, a leukemia-related gene, in concert with v-Ha-ras gene in BALB/3T3 cells. Br J Haematol 101:737–742CrossRef Sueoka E, Sueoka N, Okabe S, Komori A, Suganuma M, Kozu T, Fujiki H (1998) Tumorigenicity of MTG8, a leukemia-related gene, in concert with v-Ha-ras gene in BALB/3T3 cells. Br J Haematol 101:737–742CrossRef
go back to reference Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H (1999) Heterogeneou nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res 59:1404–1407 Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H (1999) Heterogeneou nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res 59:1404–1407
go back to reference Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H (1999) Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α -deficient mice. Cancer Res 59:4516–4518 Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H (1999) Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α -deficient mice. Cancer Res 59:4516–4518
go back to reference Suganuma M, Kurusu M, Okabe S, Sueoka N, Yoshida M, Wakatsuki Y, Fujiki H (2001) Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori. Cancer Res 61:6356–6359 Suganuma M, Kurusu M, Okabe S, Sueoka N, Yoshida M, Wakatsuki Y, Fujiki H (2001) Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori. Cancer Res 61:6356–6359
go back to reference Suganuma M, Okabe S, Kurusu M, Iida N, Ohshima S, Saeki Y, Kishimoto T, Fujiki H (2002) Discrete roles of cytokines, TNF-α, IL-1, IL-6 in tumor promotion and cell transformation. Int J Oncol 20:131–136 Suganuma M, Okabe S, Kurusu M, Iida N, Ohshima S, Saeki Y, Kishimoto T, Fujiki H (2002) Discrete roles of cytokines, TNF-α, IL-1, IL-6 in tumor promotion and cell transformation. Int J Oncol 20:131–136
go back to reference Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, Shimizu N, Tatematsu M (1998) Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 58:2067–2069PubMed Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, Shimizu N, Tatematsu M (1998) Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 58:2067–2069PubMed
go back to reference Sumie A, Yamashiro T, Nakashima K, Nasu M, Watanabe M, Nishizono A (2001) Comparison of genomic structures and antigenic reactivities of orthologous 29-kilodalton outer membrane proteins of Helicobacter pylori. Infect Immun 69:6846–6852CrossRef Sumie A, Yamashiro T, Nakashima K, Nasu M, Watanabe M, Nishizono A (2001) Comparison of genomic structures and antigenic reactivities of orthologous 29-kilodalton outer membrane proteins of Helicobacter pylori. Infect Immun 69:6846–6852CrossRef
go back to reference Takada Y, Khuri FR, Aggawal B (2004) Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-κB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-κB-regulated gene expression and up-regulation of apoptosis. J Biol Chem 279:26287–26299CrossRef Takada Y, Khuri FR, Aggawal B (2004) Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-κB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-κB-regulated gene expression and up-regulation of apoptosis. J Biol Chem 279:26287–26299CrossRef
go back to reference Tomb J-F, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC (1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539–547CrossRefPubMed Tomb J-F, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC (1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539–547CrossRefPubMed
go back to reference Tsuchihara K, Hijikata M, Fukuda K, Kuroki T, Yamamoto N, Shimotohno K (1999) Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. Viology 258:100–107CrossRef Tsuchihara K, Hijikata M, Fukuda K, Kuroki T, Yamamoto N, Shimotohno K (1999) Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. Viology 258:100–107CrossRef
go back to reference Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G (1997) Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol. Biomarkers Prev 6:639–642 Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G (1997) Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol. Biomarkers Prev 6:639–642
go back to reference Yoshida M, Wakatsuki Y, Kobayashi Y, Itoh T, Murakami K, Mizoguchi A, Usui T, Chiba T, Kita T (1999) Cloning and characterization of a novel membrane-associated antigenic protein of Helicobacter pylori. Infect Immun 67:286–293 Yoshida M, Wakatsuki Y, Kobayashi Y, Itoh T, Murakami K, Mizoguchi A, Usui T, Chiba T, Kita T (1999) Cloning and characterization of a novel membrane-associated antigenic protein of Helicobacter pylori. Infect Immun 67:286–293
go back to reference Zivny J, Wang TC, Yantiss R, Kim KH, Houghton J (2003) Role of therapy or monitoring in preventing progression to gastric cancer. J Clin Gastroenterol 36 [Suppl 5]:S50–S60 Zivny J, Wang TC, Yantiss R, Kim KH, Houghton J (2003) Role of therapy or monitoring in preventing progression to gastric cancer. J Clin Gastroenterol 36 [Suppl 5]:S50–S60
Metadata
Title
New tumor necrosis factor-α-inducing protein released from Helicobacter pylori for gastric cancer progression
Authors
Masami Suganuma
Miki Kurusu
Kaori Suzuki
Akira Nishizono
Kazunori Murakami
Toshio Fujioka
Hirota Fujiki
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 5/2005
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-004-0652-x

Other articles of this Issue 5/2005

Journal of Cancer Research and Clinical Oncology 5/2005 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.